J. Baker

发表

Development of an enzyme-linked immunosorbent assay (ELISA) to measure the level of tyrosine hydroxylase protein in brain tissue from Parkinson's disease models

R. Motter, M. Bergeron, D. Fauss, 2013, Journal of Neuroscience Methods.

Generating aldehyde-tagged antibodies with high titers and high formylglycine yields by supplementing culture media with copper(II)

P. Drake, David Rabuka, G. Bleck, 2016, BMC Biotechnology.

Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys.

M. Vásquez, H. Loibner, E. Janzek, 1993, Cancer research.

Exploring the effects of linker composition on site-specifically modified antibody-drug conjugates.

P. Drake, David Rabuka, Aaron E. Albers, 2014, European journal of medicinal chemistry.

Crystal Structure and Characterization of Human Heavy-Chain Only Antibodies Reveals a Novel, Stable Dimeric Structure Similar to Monoclonal Antibodies

G. Raghunathan, C. Strickland, D. Tomazela, 2020, Antibodies.

Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and Correction

A. Cheng, Makiko Uchida, G. Raghunathan, 2021, Antibodies.

Reconstitution of Formylglycine-generating Enzyme with Copper(II) for Aldehyde Tag Conversion

P. Drake, David Rabuka, Robyn M. Barfield, 2015, The Journal of Biological Chemistry.

Predicting Antibody Developability Profiles Through Early Stage Discovery Screening

Smita Raghava, Jeanne Baker, Yao Yu, 2020, mAbs.

Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites

W. Britt, M. Vásquez, K. Coelingh, 1993, Journal of virology.

Selective and Brain‐Permeable Polo‐like Kinase‐2 (Plk‐2) Inhibitors That Reduce α‐Synuclein Phosphorylation in Rat Brain

Kent Fitzgerald, Paul Beroza, Lee Latimer, 2013, ChemMedChem.

Aldehyde Tag Coupled with HIPS Chemistry Enables the Production of ADCs Conjugated Site-Specifically to Different Antibody Regions with Distinct in Vivo Efficacy and PK Outcomes

P. Drake, J. McFarland, David Rabuka, 2014, Bioconjugate chemistry.

Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors.

P. Beroza, R. Motter, R. Neitz, 2013, Bioorganic & medicinal chemistry letters.

Materials and Methods Humanized Anti-lewis Y Antibodies: in Vitro Properties and Pharmacokinetics in Rhesus Monkeys Protein Design Labs. Mountain View. California 94043 Fm

M. Vásquez, H. Loibner, E. Janzek, 2022 .

Structural Correlates of Antibodies Associated with Acute Reversal of Amyloid β-related Behavioral Deficits in a Mouse Model of Alzheimer Disease

T. Comery, M. Pangalos, W. Weis, 2009, The Journal of Biological Chemistry.

Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease

R. Motter, D. Kholodenko, R. Barbour, 2010, Alzheimer's Research & Therapy.

Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases

T. Shaler, N. Yao, T. Yednock, 2013, Nature Communications.

The specificity of a mouse monoclonal antibody to human aorta proteoglycans.

P. Neame, J. Baker, J. Christner, 1989, Matrix.

Correction: Label Free Fragment Screening Using Surface Plasmon Resonance as a Tool for Fragment Finding – Analyzing Parkin, a Difficult CNS Target

P. Beroza, K. Regnström, Jiangli Yan, 2013, PLoS ONE.

Label Free Fragment Screening Using Surface Plasmon Resonance as a Tool for Fragment Finding – Analyzing Parkin, a Difficult CNS Target

P. Beroza, K. Regnström, Jiangli Yan, 2013, PloS one.

Selective and Brain‐Permeable Polo‐like Kinase‐2 (Plk‐2) Inhibitors That Reduce α‐Synuclein Phosphorylation in Rat Brain

P. Beroza, R. Motter, R. Neitz, 2013, ChemMedChem.